Chromoblastomycosis epidemiology and demographics

Chromoblastomycosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Gastritis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
Endoscopy
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Chromoblastomycosis epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Chromoblastomycosis epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Chromoblastomycosis epidemiology and demographics
CDC on Chromoblastomycosis epidemiology and demographics
Chromoblastomycosis epidemiology and demographics in the news
Blogs on Chromoblastomycosis epidemiology and demographics
Directions to Hospitals Treating Chromoblastomycosis
Risk calculators and risk factors for Chromoblastomycosis epidemiology and demographics

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Epidemiology

Chromoblastomycosis occurs around the world, but is most common in rural areas between approximately 30° N and 30° S latitude. Madagascar and Japan have the highest incidence. Over two thirds of patients are male, and usually between the ages of thirty and fifty. A correlation with HLA-A29 suggests that genetic factors may play a role as well.